[
  {
    "date": "2023-12-30",
    "symbol": "NLSP",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 897680,
    "prepaidexpenseandotherassetscurrent": 925382,
    "assetscurrent": 1823062,
    "propertyplantandequipmentnet": 6694,
    "otherassetsnoncurrent": 16885,
    "assets": 1846641,
    "accountspayablecurrent": 265864,
    "shorttermnonbankloansandnotespayable": 1633746,
    "accruedliabilitiescurrent": 1652270,
    "liabilitiescurrent": 7919550,
    "deferredrevenuenoncurrent": 2499969,
    "pensionandotherpostretirementdefinedbenefitplansliabilitiesnoncurrent": 260685,
    "liabilities": 10680204,
    "commonstockvalue": 733413,
    "treasurystockvalue": 64858,
    "additionalpaidincapital": 61029437,
    "retainedearningsaccumulateddeficit": -70373484,
    "accumulatedothercomprehensiveincomelossnetoftax": -158071,
    "stockholdersequity": -8833563,
    "liabilitiesandstockholdersequity": 1846641,
    "othershorttermborrowings": 1633746,
    "commonstockparorstatedvaluepershare": 0.02,
    "commonstocksharesissued": 35671780,
    "commonstocksharesoutstanding": 35671780,
    "treasurysharesparvalue": 0.02,
    "treasurysharessharesissued": 3242887,
    "treasurysharessharesoutstanding": 3242887,
    "researchanddevelopmentexpense": 5908288,
    "generalandadministrativeexpense": 5898775,
    "operatingexpenses": 11807063,
    "operatingincomeloss": -11807063,
    "othernonoperatingincomeexpense": -219812,
    "interestexpense": 119920,
    "interestexpenserelatedparty1": 25233,
    "netincomeloss": -12172029,
    "othercomprehensiveincomelosspensionandotherpostretirementbenefitplansadjustmentnetoftax": 107280,
    "comprehensiveincomenetoftax": -12279309,
    "earningspersharebasic": -0.32,
    "weightedaveragenumberofsharesoutstandingbasic": 38176020,
    "earningspersharediluted": -0.32,
    "weightedaveragenumberofdilutedsharesoutstanding": 38176020,
    "sharesoutstanding": 35671780,
    "stockissuedduringperiodvalueother": 64858,
    "stockholdersequityothershares": 3242887,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 164907,
    "pensionexpense": 59526,
    "depreciation": 11408,
    "allocatedsharebasedcompensationexpense": 164906,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 632125,
    "increasedecreaseinaccountspayable": 2260258,
    "increasedecreaseininterestpayablenet": 25605,
    "increasedecreaseinotheraccruedliabilities": 640228,
    "increasedecreaseinothernoncurrentliabilities": -42243,
    "netcashprovidedbyusedinoperatingactivities": -9684466,
    "proceedsfromnotespayable": 1633746,
    "netcashprovidedbyusedinfinancingactivities": 1633746,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -8050720,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 897680,
    "interestpaidnet": 145153,
    "scheduleofprojectedbenefitobligationandthechangestothefairvalueoftheplanassetsofthepensionplantabletextblock": "The reconciliation of the projected benefit obligationand the changes to the fair value of the plan assets of the pension plan are shown in the following table:",
    "scheduleofunrecognizedpensioncostinaccumulatedothercomprehensiveincomelosstabletextblock": "The following table shows the components of unrecognizedpension cost in accumulated other comprehensive income/loss that have not yet been recognized as components of net periodic pension cost:",
    "scheduleofweightedaverageofthekeyassumptionsusedtocomputethebenefitobligationstabletextblock": "The weighted average of the key assumptions usedto compute the benefit obligations were as follows:",
    "vendorprepayments": 821266,
    "prepaidtaxes": 24433,
    "otherreceivables": 10664,
    "prepaidinsurance": 69019,
    "propertyplantandequipmentgross": 13341,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 32866,
    "accruedprofessionalfeescurrent": 332690,
    "accruedmarketingcostscurrent": 112635,
    "shorttermbankloansandnotespayable": 25605,
    "accruedcommitmentfee": 184672,
    "accruedbonusescurrentandnoncurrent": 960025,
    "accruedliabilitiesandotherliabilities": 36643,
    "definedbenefitplanservicecost": 53920,
    "definedbenefitplaninterestcost": 14416,
    "definedbenefitplanexpectedreturnonplanassets": 14767,
    "othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditbeforetax": -3031,
    "definedbenefitplanothercosts": 2926,
    "definedbenefitplannetperiodicbenefitcost": 59525,
    "definedbenefitplanbenefitobligation": 809028,
    "definedbenefitplanfairvalueofplanassets": 548343,
    "definedbenefitplanotherchanges": 38654,
    "definedbenefitplanactuarialgainloss": -123388,
    "definedbenefitplanforeigncurrencyexchangeratechangesbenefitobligation": 6087,
    "definedbenefitplanactualreturnonplanassets": 27844,
    "definedbenefitplancontributionsbyemployer": 38737,
    "definedbenefitplanplanassetscontributionsbyplanparticipant": 20655,
    "definedbenefitplanassetstransferredtofromplan": 17999,
    "definedbenefitplanadministrationexpenses": 2926,
    "definedbenefitplanplanassetsforeigncurrencytranslationgainloss": -2581,
    "accumulatedothercomprehensiveincomelossdefinedbenefitpensionandotherpostretirementplansnetoftax": -158073,
    "othercomprehensiveincomedefinedbenefitplansnetunamortizedgainlossarisingduringperiodnetoftax": 110313,
    "othercomprehensiveincomelosspensionandotherpostretirementbenefitplansadjustmentbeforetax": 161104,
    "othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditnetoftax": 3031,
    "othercomprehensiveincomedefinedbenefitplansadjustmentnetoftaxportionattributabletoparent": -3031,
    "definedbenefitplanassumptionsusedcalculatingbenefitobligationdiscountrate": 0.0145,
    "definedbenefitplanassumptionsusedcalculatingbenefitobligationrateofcompensationincrease": 0.0065,
    "definedbenefitplanassumptionsusedcalculatingbenefitobligationweightedaverageinterestcreditingrate": 0.0145,
    "definedbenefitplanassumptionsusedcalculatingbenefitobligationexpectedlongtermreturnonassets": 0.023,
    "definedbenefitplanassumptionsusedcalculatingnetperiodicbenefitcostinflationrate": 0.0125,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 19045043,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 307844,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1863658,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 776344,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 245809,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 0.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 449515,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1414143,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 1414146,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 0.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 399515,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 0.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 245809,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 0.27,
    "deferredtaxassetsoperatinglosscarryforwards": 4337728,
    "deferredtaxassetsdeferredincome": 264997,
    "deferredtaxassetsvaluationallowance": 4602725,
    "deferredincometaxexpensebenefit": 852486,
    "othertaxexpensebenefit": 852486,
    "incometaxexpensebenefitcontinuingoperationsadjustmentofdeferredtaxassetliability": -852486,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.106,
    "effectiveincometaxratereconciliationotheradjustments": -0.036,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.07,
    "classofwarrantorrightreasonforissuingtononemployees": "Eachunit consisted of one common share and one warrant to purchase one common share (the “Warrants”).",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.497,
    "taxbenefitsmorelikelytoberecognizedpercentage": 0.5,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5747127,
    "debtinstrumentinterestratestatedpercentage": 0.1,
    "debtinstrumentunamortizeddiscount": 67008,
    "debtinstrumentconvertibletermsofconversionfeature": "the notes were able to be voluntarily convertedinto common shares of the Company prior to the maturity date at a 20% discount (i) to any subsequent qualified equity financing roundof at least $6 million in the aggregate or (ii) upon a change of control.",
    "debtunregisteredwarrantallocation": "the noteholders received unregistered warrants to purchase common shares of the Company equalto an aggregate of 10% of the note amount of each noteholder, divided by $0.4970",
    "nonrefundableupfrontpayment": 2500000,
    "receivenonrefundablemilestonepayments": 16000000,
    "estimatedtotaltransactionprice": 2500000,
    "deferredrevenuerevenuerecognized1": 2500000,
    "deferredrevenue": 2500000,
    "definedbenefitplannetperiodicbenefitcostcreditexcludingservicecoststatementofincomeorcomprehensiveincomeextensiblelist": "http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
    "projectedbenefitobligationspercentagerate": 0.1,
    "licenseconsideration": 250000,
    "milestonepaymentsduedescription": "(i) $750,000 payable following the end of a Phase II meeting with the FDA, with the amount tobe reduced to $375,000 if toxicology studies must be repeated; (ii) $2 million following the earlier of U.S. Food and Drug Administration(“FDA”) marketing authorization of Quilience or Nolazol; (iii) 1% of any upfront and milestone payments, if any, fromany sublicensees and (iv) $3 million as a one-time payment upon the Company’s product candidate reaching $250 million in cumulativesales.",
    "paymentsofstockissuancecosts": 700000,
    "aggregategrossproceedspercentage": 0.05,
    "unitofferingmaximum": 20000000,
    "numberofcommonsharespercentage": 1.5,
    "unitpriceperunit": 1.5,
    "exercisepricepershare": 2.03,
    "cashplacement": 140000,
    "commissionratepercentage": 0.03,
    "commonsharewarrants": 3304492,
    "treasurystockcommonshares": 3242887,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y9M18D",
    "shareprice": 0.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 54899,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 471347,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y9M14D",
    "operatinglosscarryforwards": 40900000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 15500000,
    "relatedpartytransactionamountsoftransaction": 121658,
    "deconsolidationrelatedpartydescription": "the Company has agreed to pay CHG BioVenture SA a monthly fee CHF 4’375 ($4,733) plus 7.7% VAT for his services.In addition, CHG BioVenture SA is eligible for a 1% success fee payment in the event of closing of a partnering agreement in China.",
    "addendumstoshorttermloanagreements": "the Company entered into twoaddendums to the Short Term Loan Agreements with Ronald Hafner, the Company’s Chairman of the Board of Directors. These addendumsextend the maturity date under the Loan Agreements to June 30, 2025, for the aggregate amount of CHF 750,000.",
    "entityregistrantname": "NLS PHARMACEUTICS LTD.",
    "tradingsymbol": "NLSP",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 35671780,
    "amendmentflag": "false",
    "entitycentralindexkey": 1783036,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39957",
    "entityincorporationstatecountrycode": "V8",
    "entityaddressaddressline1": "The Circle 6",
    "entityaddresspostalzipcode": 8058,
    "entityaddresscityortown": "Zurich",
    "entityaddresscountry": "CH",
    "contactpersonnelname": "Alexander Zwyer",
    "cityareacode": 41,
    "localphonenumber": "44 512 21 50",
    "contactpersonnelemailaddress": "@nls-pharma.com",
    "entityaddressaddressline2": "Postfach",
    "security12btitle": "Common shares, nominal value CHF 0.02 per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1358,
    "auditorname": "PricewaterhouseCoopers AG",
    "auditorlocation": "Zurich, Switzerland"
  },
  {
    "date": "2022-12-31",
    "symbol": "NLSP",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 8948400,
    "prepaidexpensecurrent": 297998,
    "assetscurrent": 9246398,
    "propertyplantandequipmentnet": 18102,
    "otherassetsnoncurrent": 12143,
    "assets": 9276643,
    "accountspayablecurrent": 2373276,
    "accruedliabilitiescurrent": 986437,
    "liabilitiescurrent": 3359713,
    "deferredrevenuenoncurrent": 2499969,
    "accruedemployeebenefitscurrentandnoncurrent": 136122,
    "liabilities": 5995804,
    "commonstockvalue": 668555,
    "additionalpaidincapital": 60864530,
    "retainedearningsaccumulateddeficit": -58201455,
    "accumulatedothercomprehensiveincomelossnetoftax": -50791,
    "stockholdersequity": -50791,
    "liabilitiesandstockholdersequity": 9276643,
    "accountspayableincludingrelatedparty": 53365,
    "otheraccruedliabilitiescurrent": 4107,
    "commonstockparorstatedvaluepershare": 0.02,
    "commonstocksharesissued": 32428893,
    "commonstocksharesoutstanding": 32428893,
    "researchanddevelopmentexpense": 8976643,
    "generalandadministrativeexpense": 6505721,
    "operatingexpenses": 15482364,
    "operatingincomeloss": -15482364,
    "othernonoperatingincomeexpense": 10045,
    "interestexpensedebt": 95211,
    "interestexpenseother": 5655,
    "lossonconversionofdebts": -922495,
    "profitloss": -16495680,
    "definedpensionplanadjustments": -100948,
    "comprehensiveincomenetoftax": -16394732,
    "earningspersharebasic": -0.84,
    "weightedaveragenumberofsharesoutstandingbasic": 19682643,
    "earningspersharediluted": -0.84,
    "weightedaveragenumberofdilutedsharesoutstanding": 19682643,
    "sharesoutstanding": 32428893,
    "stockandwarrantsissuedduringperiodvaluepreferredstockandwarrants": 2047208,
    "issuanceofcommonsharesinregistereddirectofferingnet": 1911513,
    "stockissuedduringperiodsharesother": 1562531,
    "issuanceofprefundedwarrantsnet": 5348882,
    "issuanceofcommonsharesinatthemarketatmfinancing": 30993,
    "stockissuedduringperiodvalueacquisitions": -116184,
    "stockissuedduringperiodsharesacquisitions": 5809243,
    "stockissuedduringperiodvaluestockoptionsexercised": 23692,
    "issuanceofcommonsharesinprivateplacementofferingsnet": 7275549,
    "issuanceofcommonsharesinprivateplacementofferingsnetinshares": 6317301,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithconversionfeature": 2472616,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 2516429,
    "stockissuedduringperiodvaluesharebasedcompensation": 22730,
    "othercomprehensiveincomelosspensionandotherpostretirementbenefitplansbeforereclassificationadjustmentstax": 100948,
    "netincomeloss": -16495680,
    "periodicpensioncosts": 34142,
    "depreciation": 11408,
    "sharebasedcompensation": 22730,
    "amortizationofdebtdiscountpremium": 67008,
    "lossonconversionofdebt": 922495,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -698116,
    "increasedecreaseinaccountspayable": 636263,
    "increasedecreaseinaccruedtaxespayable": 20121,
    "increasedecreaseinotheraccruedliabilities": 319989,
    "increasedecreaseinotherlongtermliabilitie": 47679,
    "netcashprovidedbyusedinoperatingactivities": -13879371,
    "proceedsfromtheissuanceofcommonsharesinatmfinancing": 30993,
    "proceedsfromissuanceofcommonstock": 1911513,
    "proceedsfromissuanceofprivateplacement": 7275549,
    "proceedsfromtheissuanceofprefundedwarrantsnet": 5348882,
    "proceedsfromstockplans": 1530000,
    "proceedsfromstockoptionsexercised": 23692,
    "repaymentsofnotespayable": 704160,
    "proceedsfromissuanceofwarrants": 1980200,
    "netcashprovidedbyusedinfinancingactivities": 17396669,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -100,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 3517198,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 8948400,
    "cashpaidforinterest": 13248,
    "stockissued1": 704160,
    "debtdiscountonconvertibleloans": 67008,
    "backgroundtextblock": "Note 1 ",
    "notepayabletextblock": "Note 6 ",
    "shorttermconvertiblenotestextblock": "Note 7 ",
    "pensionliabilitytextblock": "Note 9 ",
    "sharecapitalandpublicofferingstextblock": "Note 11 ",
    "scheduleofweightedaverageofthekeyassumptionsusedtocomputethebenefitobligationstabletextblock": "            2022      2021       Discount rate      2.25%      0.30%      Rate of increase in compensation level      0.25%      0.00%      Interest credit rate on savings accounts      2.25%      1.00%      Expected long-term rate of return on plan assets      2.95%      2.00%      Inflation rate      0.85%      0.60%   ",
    "scheduleofcommonsharewarrantactivitytabletextblock": "      Balance at January 1, 2022      5,409,746       Issuances      14,819,913       Exercises      (1,184,616)      Balance at December 31, 2022      19,045,043    ",
    "scheduleofunvestedstockoptionactivitytabletextblock": "            Non-Vested    Options      Weighted    Average    Grant date    Fair Value                            Balance at December 31, 2021      -       -       Granted      1,333,123       -       Vested      (50,000)     $0.22       Forfeited      -               Balance at December 31, 2022      1,283,123      $0.25    ",
    "vendorprepayments": 65739,
    "prepaidtaxes": 41243,
    "prepaidinsurance": 36496,
    "prepaidexpensecurrentandnoncurrent": 154520,
    "prepaidexpenseandotherassetscurrent": 297998,
    "propertyplantandequipmentgross": 39560,
    "accumulateddepreciationdepletionandamortizationsaleofpropertyplantandequipment1": 21458,
    "propertyplantandequipmentownedgross": 18102,
    "accruedprofessionalfeescurrent": 285398,
    "accruedmarketingcostscurrent": 13000,
    "duetorelatedpartyexpenses": 4107,
    "accruedprofessionalfeescurrentandnoncurrent": 149496,
    "accruedbonusescurrentandnoncurrent": 510678,
    "accruedliabilitiesandotherliabilities": 23758,
    "otheraccruedliabilitiescurrentandnoncurrent": 986437,
    "definedbenefitplanservicecost": 39667,
    "interestcostsincurred": 2743,
    "expectedreturnonassets": -12196,
    "definedbenefitplanbenefitobligationpaymentforsettlement": -72600,
    "actuariallossoutsidecorridorrecognized": 3091,
    "pastservicecostrecognized": 2855,
    "definedcontributionplanadministrativeexpenses": 2298,
    "netperiodicpensioncost": -34142,
    "projectedbenefitobligationbeginningandending": 584737,
    "projectedbenefitobligationservicecost": 39667,
    "projectedbenefitobligationinterestcost": 2743,
    "projectedbenefitobligationtransfersinandoutnet": -209035,
    "projectedbenefitobligationactuarialgainloss": -152048,
    "projectedbenefitobligationcurrencyconversionadjustments": -23959,
    "planassetsbeginningandending": 448615,
    "definedbenefitplanactualreturnonplanassets": -51764,
    "planassetsemployercontributions": 37468,
    "planassetsparticipantcontributions": 20608,
    "planassetstransfersinandoutnet": -150129,
    "planassetsadministrationexpenses": -2299,
    "planassetscurrencyconversionadjustments": -13747,
    "accruedpensionliability": 136122,
    "othergainlossduringtheperiod": -88088,
    "otherprioryeargainlossrecognizedinperiod": -3091,
    "effectofsettlement": -6913,
    "netlossinandending": 53647,
    "amortizationofpriorservicecost": -2856,
    "priorservicecostending": -2856,
    "totalunrecognizedpensioncostendofperiod": 50791,
    "weightedaveragediscountrate": 0.0225,
    "rateofincreaseincompensationlevel": 0.0025,
    "interestcreditrateonsavingsaccountsindollars": 0.0225,
    "expectedlongtermrateofreturnonplanassets": 0.029500000000000002,
    "weightedaverageinflationrate": 0.0085,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 19045043,
    "proceedstoissuancewarrants": 14819913,
    "stockissuedduringperiodoptionsexercised": -1184616,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1333123,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1333123,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1283123,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 1283123,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 0.22,
    "deferredtaxassetsoperatinglosscarryforwards": 3485242,
    "deferredrevenuecurrent": 264997,
    "deferredtaxassetsvaluationallowance": 3750239,
    "deferredincometaxexpensebenefit": 1004681,
    "deferredtaxassetsgross": 1004681,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1004681,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.106,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.048,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.057999999999999996,
    "saleofstockpricepershare": 1.5,
    "retainedearningsunappropriated": 58200000,
    "otheroperatingincome": 16300000,
    "restrictedcashandcashequivalents": 8900000,
    "resultsofoperationssalesortransferstoentitysotheroperations": 18500000,
    "registrationpaymentarrangementmaximumpotentialconsideration": 230000,
    "stockholdersequitystocksplit": "The Company has access to the funds under SEDA with some limitations, including YA’sownership cannot exceed a maximum of 9.99% of the outstanding common shares and the Company cannot issue common shares to YA in excessof the common shares registered on its registration statement.",
    "taxbenefitsmorelikelytoberecognizedpercentage": 0.5,
    "incrementalcommonsharesattributabletocalloptionsandwarrants": 13297916,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 11408,
    "debtinstrumentinterestrateeffectivepercentage": 0.039,
    "debtinstrumentinterestratestatedpercentage": 0.1,
    "percentageofunamortizedfilmcosts": 0.2,
    "equityfinancingroundamount": 6000000,
    "aggregatepercentage": 0.1,
    "commonsharesdividedpershare": 0.497,
    "aggregateshare": 307844,
    "warrantexercisepricedecrease": 0.497,
    "fairvalueadjustmentofwarrants": 67008,
    "nonrefundableupfrontpayment": 2500000,
    "receivenonrefundablemilestonepayments": 16000000,
    "estimatedtotaltransactionprice": 2500000,
    "deferredrevenuerevenuerecognized1": 2500000,
    "longtermdeferredrevenue": 2500000,
    "projectedbenefitobligationspercentagerate": 0.1,
    "unrecognizedpensioncosts": 50792,
    "accumulatedbenefitobligation": 584737,
    "issuedcommonshares": 32428893,
    "warrantstopurchase": 1258215,
    "cashplacementfee": 700000,
    "aggregategrossproceedspercentage": 0.05,
    "numberofcommonsharespercentage": 1.5,
    "exercisepricepershare": 1.04,
    "cashplacementfeepercentage": 0.07,
    "aggregateprincipalbalance": 1530000,
    "excessstocksharesissued": 2516429,
    "purchaseofcommonshares": 3150000,
    "commissionratepercentage": 0.03,
    "commonsharewarrants": 10605284,
    "sharebasedcompensationarrangementbysharebasedpaymentawardgrantterm": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 9.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 9.9,
    "shareprice": 1.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 154270,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 306508,
    "financeleaseweightedaverageremainingleaseterm1": 2.25,
    "descriptionofincometaxdescription": "The Company has Swiss tax loss carryforwards of$32.4 million as of December 31, 2022 (December 31, 2021: $23.6 million) of which $15.5 million will expire within the next five years,and $16.9 million will expire between 2028 - 2029. ",
    "netoperatingloss": 9700000,
    "relatedpartytransactionsellinggeneralandadministrativeexpensesfromtransactionswithrelatedparty": 131941,
    "deconsolidationrelatedpartydescription": "the Company has agreed to pay CHG BioVenture SA a monthly fee CHF 4’375 ($4,733) plus 7.7% VAT for his services.In addition, CHG BioVenture SA is eligible for a 1% success fee payment in the event of closing of a partnering agreement in China.",
    "paymentsforfees": 16000,
    "salariesandwages": 12500,
    "entityregistrantname": "NLS PHARMACEUTICS LTD.",
    "tradingsymbol": "NLSP",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 32428893,
    "amendmentflag": "false",
    "entitycentralindexkey": 1783036,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39957",
    "entityincorporationstatecountrycode": "Switzerland",
    "entityaddressaddressline1": "The Circle 6",
    "entityaddresspostalzipcode": 8058,
    "entityaddresscityortown": "Zurich",
    "entityaddresscountry": "Switzerland",
    "contactpersonnelname": "Alexander Zwyer",
    "cityareacode": 41,
    "localphonenumber": "44 512 21 50",
    "contactpersonnelemailaddress": "@nls-pharma.com",
    "entityaddressaddressline2": "Postfach",
    "security12btitle": "Common shares, nominal value CHF 0.02 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1358,
    "auditorname": "PricewaterhouseCoopers AG",
    "auditorlocation": "Zurich, Switzerland"
  },
  {
    "date": "2021-12-31",
    "symbol": "NLSP",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 5431202,
    "prepaidexpensecurrent": 291954,
    "assetscurrent": 5723156,
    "propertyplantandequipmentnet": 29510,
    "otherassetsnoncurrent": 12044,
    "assets": 5764710,
    "accountspayablecurrent": 1737013,
    "accruedliabilitiescurrent": 666449,
    "liabilitiescurrent": 2403462,
    "deferredrevenuenoncurrent": 2499969,
    "accruedemployeebenefitscurrentandnoncurrent": 318891,
    "liabilities": 5222322,
    "commonstockvalue": 344445,
    "treasurystockvalue": 29497,
    "additionalpaidincapital": 42084954,
    "retainedearningsaccumulateddeficit": -41705775,
    "accumulatedothercomprehensiveincomelossnetoftax": -151739,
    "stockholdersequity": -151739,
    "liabilitiesandstockholdersequity": 5764710,
    "accountspayableincludingrelatedparty": 62231,
    "otheraccruedliabilitiescurrent": 6877,
    "commonstockparorstatedvaluepershare": 0.02,
    "commonstocksharesissued": 16223389,
    "commonstocksharesoutstanding": 6960000,
    "researchanddevelopmentexpense": 5919452,
    "generalandadministrativeexpense": 5941169,
    "operatingexpenses": 11860621,
    "operatingincomeloss": -11860621,
    "othernonoperatingincomeexpense": -17323,
    "interestexpensedebt": 48100,
    "interestexpenseother": 20034,
    "profitloss": -11946078,
    "definedpensionplanadjustments": 132358,
    "comprehensiveincomenetoftax": -12078436,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -1,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 11901636,
    "sharesoutstanding": 16223389,
    "stockissuedduringperiodvaluenewissues": 10054657,
    "stockissuedduringperiodsharesnewissues": 4819277,
    "stockandwarrantsissuedduringperiodvaluepreferredstockandwarrants": 6742638,
    "stockissuedduringperiodvalueissuedforservices": 50000,
    "stockissuedduringperiodsharesissuedforservices": 12048,
    "stockissuedduringperiodvalueother": 1149550,
    "stockissuedduringperiodsharesstockoptionsexercised": 277000,
    "issuanceofcommonsharesinequitytransaction": 3548581,
    "issuanceofcommonsharesinequitytransactionsinshares": 1313232,
    "issuanceofcommonsharesforpartialcommitmentfees": 59455,
    "issuanceofcommonsharesforpartialcommitmentfeeinshares": 26203,
    "capitalincreaseforfinancingtransactions": -56313,
    "capitalincreaseforfinancingtransactionsinshares": 2815629,
    "othercomprehensiveincomelosspensionandotherpostretirementbenefitplansbeforereclassificationadjustmentstax": -132358,
    "netincomeloss": -11946078,
    "periodicpensioncosts": -47183,
    "depreciation": 10050,
    "gainslossesonextinguishmentofdebt": -77714,
    "amortizationofdebtdiscountpremium": 41611,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 188954,
    "increasedecreaseinaccountsreceivablerelatedparties": 21804,
    "increasedecreaseinaccountspayable": -2269460,
    "increasedecreaseinaccruedtaxespayable": -313342,
    "increasedecreaseinotheraccruedliabilities": -372964,
    "netcashprovidedbyusedinoperatingactivities": -14936044,
    "paymentstoacquirepropertyplantandequipment": 39560,
    "netcashprovidedbyusedininvestingactivities": -39560,
    "proceedsfromissuanceinitialpublicoffering": 11001569,
    "proceedsfromissuanceofwarrants": 6742638,
    "proceedsfromwarrantexercises": 1149550,
    "proceedsfrombridgeloans": 108610,
    "paymentonswissgovernmentloans": -277537,
    "repaymentsoflinesofcredit": 150000,
    "paymentonconvertibleloans": -420020,
    "paymentonconvertibleloansrelatedparty": -111730,
    "paymentonbridgeloan": -670380,
    "repaymentsofrelatedpartydebt": 583443,
    "proceedsfromissuanceofcommonstock": 3548582,
    "netcashprovidedbyusedinfinancingactivities": 20337839,
    "effectofexchangerateoncashandcashequivalents": -24744,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 5337491,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 5431202,
    "cashpaidforinterest": 339932,
    "deferredofferingcosts": 946912,
    "issuanceofcommonsharestoconsultantforpaymentofexpenses": 50000,
    "issuanceofcommonsharestoyorkvilleforpartialpaymentofcommitmentfees": 59455,
    "backgroundtextblock": "Note 1",
    "convertiblepromissorynotesrelatedpartiestextblock": "Note 6",
    "bridgeloantextblock": "Note 9",
    "swissgovernmentloandisclosuretextblock": "Note 11",
    "pensionliabilitytextblock": "Note 13",
    "sharecapitalandpublicofferingstextblock": "Note 15",
    "scheduleofconvertibleloanstabletextblock": "            December 31, 2020                     Convertible loans, net of discount of $41,611     $383,313       Convertible loans – related party      113,130              496,443       Less: current portion      (463,980)                     Convertible loans, long term     $32,463    ",
    "scheduleofweightedaverageofthekeyassumptionsusedtocomputethebenefitobligationstabletextblock": "            2021      2020       Discount rate      0.30%      0.15%      Rate of increase in compensation level      0.00%      0.00%      Interest credit rate on savings accounts      1.00%      1.00%      Expected long-term rate of return on plan assets      2.00%      2.00%      Inflation rate      0.60%      0.60%   ",
    "scheduleofcommonsharewarrantactivitytabletextblock": "      Balance at January 1, 2021     -       Issuances      5,686,746       Exercises      (277,000)      Balance at December 31, 2021      5,409,746    ",
    "vendorprepayments": 37538,
    "prepaidtaxes": 38551,
    "prepaidinsurance": 187446,
    "prepaidexpensecurrentandnoncurrent": 28419,
    "prepaidexpenseandotherassetscurrent": 291954,
    "propertyplantandequipmentgross": 39560,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 10050,
    "accruedprofessionalfeescurrent": 244245,
    "accruedmarketingcostscurrent": 16954,
    "duetorelatedpartyexpenses": 6877,
    "accruedprofessionalfeescurrentandnoncurrent": 137002,
    "accruedcommitmentfee": 200000,
    "accruedliabilitiesandotherliabilities": 61371,
    "otheraccruedliabilitiescurrentandnoncurrent": 666449,
    "definedbenefitplanservicecost": 48641,
    "definedbenefitplaninterestcost": 732,
    "expectedreturnonassets": -6314,
    "actuariallossoutsidecorridorrecognized": 983,
    "definedcontributionplanadministrativeexpenses": 3141,
    "netperiodicpensioncost": 47183,
    "projectedbenefitobligationbeginningandending": 927369,
    "projectedbenefitobligationservicecost": 48641,
    "projectedbenefitobligationinterestcost": 732,
    "projectedbenefitobligationtransfersinandoutnet": 442557,
    "projectedbenefitobligationactuarialgainloss": 167864,
    "projectedbenefitobligationcurrencyconversionadjustments": -6100,
    "planassetsbeginningandending": 608478,
    "definedbenefitplanactualreturnonplanassets": 70634,
    "planassetsemployercontributions": 34062,
    "planassetsparticipantcontributions": 20738,
    "planassetstransfersinandoutnet": 392021,
    "planassetsadministrationexpenses": -3141,
    "planassetscurrencyconversionadjustments": -1242,
    "accruedpensionliability": 318891,
    "netlossinbeginningandending": 121942,
    "othergainlossduringtheperiod": 103544,
    "otherprioryeargainlossrecognizedinperiod": -983,
    "priorservicecostbeginning": 29797,
    "amortizationofpriorservicecost": 29797,
    "totalunrecognizedpensioncostendofperiod": 151739,
    "weightedaveragediscountrate": 0.003,
    "interestcreditrateonsavingsaccountsindollars": 0.01,
    "expectedlongtermrateofreturnonplanassets": 0.02,
    "weightedaverageinflationrate": 0.006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 5409746,
    "proceedstoissuancewarrants": 5686746,
    "stockissuedduringperiodoptionsexercised": -277000,
    "deferredtaxassetsoperatinglosscarryforwards": 2504647,
    "deferredrevenuecurrent": 264997,
    "otherdeferredtaxnet": -24086,
    "deferredtaxassetsvaluationallowance": 2745558,
    "deferredincometaxexpensebenefit": 1119614,
    "deferredtaxassetsgross": 1119614,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1119614,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.106,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.036000000000000004,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.07,
    "retainedearningsunappropriated": 41700000,
    "otheroperatingincome": 11900000,
    "resultsofoperationssalesortransferstoentitysotheroperations": 18500000,
    "registrationpaymentarrangementmaximumpotentialconsideration": 3900000,
    "taxbenefitsmorelikelytoberecognizedpercentage": 0.5,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5409746,
    "annualnetsalespercentage": 0.018000000000000002,
    "royaltypaymentpercentage": 0.009000000000000001,
    "debtinstrumentmaturitydaterangeend1": "March 31, 2021",
    "lineofcreditfacilityaverageoutstandingamount": 150000,
    "depositliabilitiesaccruedinterest": 85737,
    "creditfacilitymaturitydates": "March 31, 2021",
    "adjustmentforamortization": 41611,
    "nonrefundableupfrontpayment": 2500000,
    "receivenonrefundablemilestonepayments": 16000000,
    "estimatedtotaltransactionprice": 2500000,
    "deferredrevenuerevenuerecognized1": 2500000,
    "longtermdeferredrevenue": 2500000,
    "projectedbenefitobligationspercentagerate": 0.1,
    "unrecognizedpensioncosts": 151739,
    "accumulatedbenefitobligation": 927369,
    "issuedcommonshares": 16223389,
    "companyutilizeseda": 20000000,
    "significantsupplycommitmentremainingminimumamountcommitted": 400000,
    "commitmentfeepercenatge": 0.02,
    "commonstocksharessubscribedbutunissued": 26203,
    "initialportionofcommitmentfee": 140545,
    "paymentsforproceedsfromrealestatepartnershipinvestmentnet": 17000000,
    "exercisepricepershare": 4.15,
    "debtconversionconvertedinstrumentwarrantsoroptionsissued1": 144578,
    "compensationoftotalunitssold": 0.03,
    "proceedsfromstockoptionsexercised": 5.1875,
    "fairvalueadjustmentofwarrants": 303847,
    "treasurystockshares": 1474853,
    "descriptionofincometaxdescription": "The Company has Swiss tax loss carryforwards of$23.6 million as of December 31, 2021 (December 31, 2020: $15.5 million) of which $11.5 million will expire within the next five years,and $12.1 million will expire between 2027 - 2028. ",
    "netoperatingloss": 9700000,
    "duetorelatedpartiescurrent": 126326,
    "relatedpartytransactionsellinggeneralandadministrativeexpensesfromtransactionswithrelatedparty": 101717,
    "deconsolidationrelatedpartydescription": "the Company has agreed to pay CHG BioVenture SA a monthly fee CHF 4’375 ($4,733) plus 7.7% VAT for his services.In addition, CHG BioVenture SA is eligible for a 1% success fee payment in the event of closing of a partnering agreement in China.",
    "debtcommissionrates": 0.03,
    "entityregistrantname": "NLS PHARMACEUTICS LTD.",
    "tradingsymbol": "NLSP",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 16223389,
    "amendmentflag": "false",
    "entitycentralindexkey": 1783036,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "No",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39957",
    "entityincorporationstatecountrycode": "Switzerland",
    "entityaddressaddressline1": "The Circle 6,",
    "entityaddresspostalzipcode": 8058,
    "entityaddresscityortown": "Zurich",
    "entityaddresscountry": "Switzerland",
    "contactpersonnelname": "Alexander Zwyer",
    "cityareacode": 41,
    "localphonenumber": "44 512 21 50",
    "contactpersonnelemailaddress": "@nls-pharma.com",
    "entityaddressaddressline2": "Postfach",
    "security12btitle": "Common Shares, nominal value CHF 0.02 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1358,
    "auditorname": "PricewaterhouseCoopers AG",
    "auditorlocation": "Zurich, Switzerland"
  },
  {
    "date": "2020-12-31",
    "symbol": "NLSP",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 93711,
    "prepaidexpensecurrent": 103000,
    "assetscurrent": 196711,
    "deferredcosts": 946912,
    "accountsandotherreceivablesnetcurrent": 67954,
    "assets": 1211577,
    "accountspayablecurrent": 4006473,
    "interestpayablecurrent": 316174,
    "convertiblenotespayablecurrent": 591693,
    "linesofcreditcurrent": 150000,
    "convertibledebtcurrent": 463980,
    "bridgeloan": 565650,
    "accountspayableandotheraccruedliabilitiescurrent": 459195,
    "accruedliabilitiescurrent": 650753,
    "liabilitiescurrent": 7203918,
    "convertibledebtnoncurrent": 32463,
    "longtermloansfrombank": 281015,
    "deferredrevenuenoncurrent": 2499969,
    "accruedemployeebenefitscurrentandnoncurrent": 178269,
    "liabilities": 10195634,
    "commonstockvalue": 145139,
    "additionalpaidincapital": 20649882,
    "retainedearningsaccumulateddeficit": -29759697,
    "accumulatedothercomprehensiveincomelossnetoftax": -19381,
    "stockholdersequity": -19381,
    "liabilitiesandstockholdersequity": 1211577,
    "accountspayableincludingrelatedparty": 454315,
    "longtermdebt": 113130,
    "debtinstrumentunamortizeddiscountcurrent": 37362,
    "otheraccruedliabilitiescurrent": 40842,
    "debtinstrumentunamortizeddiscountnoncurrent": 4248,
    "commonstockparorstatedvaluepershare": 0.02,
    "commonstocksharesissued": 6960000,
    "commonstocksharesoutstanding": 6960000,
    "commonstocksharesauthorized": 10440000,
    "researchanddevelopmentexpense": 99580,
    "generalandadministrativeexpense": 2199790,
    "operatingexpenses": 2299370,
    "operatingincomeloss": -2299370,
    "othernonoperatingincomeexpense": -328365,
    "interestexpensedebt": 86792,
    "interestexpenseother": 146908,
    "profitloss": -2861435,
    "definedpensionplanadjustments": 683,
    "comprehensiveincomenetoftax": -2862118,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -0.41,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 6960000,
    "sharesoutstanding": 6960000,
    "debtinstrumentconvertiblebeneficialconversionfeature": 24911,
    "beneficialconversionfeatureonrelatedpartyconvertibleloan": 24100,
    "othercomprehensiveincomelosspensionandotherpostretirementbenefitplansbeforereclassificationadjustmentstax": -683,
    "netincomeloss": -2861435,
    "periodicpensioncosts": 4258,
    "amortizationofdebtdiscountpremium": 72188,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 3477,
    "increasedecreaseinaccountsreceivablerelatedparties": 13482,
    "increasedecreaseinaccountspayable": 1497123,
    "increasedecreaseinaccruedtaxespayable": 137826,
    "increasedecreaseinotheraccruedliabilities": 446129,
    "netcashprovidedbyusedinoperatingactivities": -729386,
    "proceedsfromnotespayable": 249306,
    "proceedsfromconvertibledebt": 113130,
    "proceedsfromswissgovernmentloan": 262137,
    "proceedsfrombridgeloan": -565650,
    "paymentsoffinancingcosts": 686701,
    "netcashprovidedbyusedinfinancingactivities": 503522,
    "effectofexchangerateoncashandcashequivalents": 99308,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -126556,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 93711,
    "prepaidvendoroverpayments": 27380,
    "prepaidtaxes": 61207,
    "prepaidexpensecurrentandnoncurrent": 14413,
    "prepaidexpenseandotherassetscurrent": 103000,
    "secondcreditfacility": 150000,
    "debtdiscount": 41611,
    "debtinstrumentunamortizeddiscountpremiumnet": -383313,
    "convertibledebt": 496443,
    "definedbenefitplanservicecost": 24875,
    "definedbenefitplaninterestcost": 832,
    "expectedreturnonassets": -1713,
    "definedbenefitplanbenefitobligationpaymentforsettlement": -28754,
    "definedcontributionplanadministrativeexpenses": 1185,
    "netperiodicpensioncost": -3575,
    "projectedbenefitobligationbeginningandending": 273675,
    "projectedbenefitobligationservicecost": 24875,
    "projectedbenefitobligationinterestcost": 832,
    "projectedbenefitobligationtransfersinandoutnet": -169942,
    "projectedbenefitobligationactuarialgainloss": 3561,
    "projectedbenefitobligationcurrencyconversionadjustments": 28285,
    "planassetsbeginningandending": 95406,
    "definedbenefitplanactualreturnonplanassets": -620,
    "planassetsemployercontributions": 15207,
    "planassetsparticipantcontributions": 6954,
    "planassetstransfersinandoutnet": -142931,
    "planassetsadministrationexpenses": -1185,
    "planassetscurrencyconversionadjustments": 12165,
    "accruedpensionliability": 178269,
    "netlossinbeginningandending": 19381,
    "othergainlossduringtheperiod": 5895,
    "effectofsettlement": -5212,
    "totalunrecognizedpensioncostendofperiod": 19381,
    "weightedaveragediscountrate": 0.0015,
    "interestcreditrateonsavingsaccountsindollars": 0.01,
    "expectedlongtermrateofreturnonplanassets": 0.02,
    "weightedaverageinflationrate": 0.006,
    "deferredtaxassetsoperatinglosscarryforwards": 1393809,
    "deferredrevenuecurrent": 224997,
    "otherdeferredtaxnet": 6951,
    "deferredtaxassetsvaluationallowance": 1625757,
    "deferredincometaxexpensebenefit": 384301,
    "deferredtaxassetsgross": 384301,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 384301,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.09,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.039,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.129,
    "grossproceeds": 17000000,
    "otheroperatingincome": 2300000,
    "stockholdersequity1": 8984057,
    "deferredcostscurrent": 946912,
    "taxbenefitsmorelikelytoberecognizedpercentage": 0.5,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 50205,
    "annualnetsalespercentage": 0.018,
    "royaltypaymentpercentage": 0.009,
    "otherlongtermdebt": 67954,
    "longtermdebtpercentagebearingvariableinterestrate": 0.1,
    "debtinstrumentmaturitydate": "2021-03-31",
    "lineofcreditfacilityaverageoutstandingamount": 150000,
    "depositliabilitiesaccruedinterest": 85737,
    "adjustmentforamortization": 48088,
    "interestexpensedebtexcludingamortization": 24100,
    "interestpayablecurrentandnoncurrent": 48634,
    "projectedbenefitobligationspercentagerate": 0.1,
    "unrecognizedpensioncosts": 19381,
    "accumulatedbenefitobligation": 273675,
    "nonrefundableupfrontpayment": 2500000,
    "receivenonrefundablemilestonepayments": 16000000,
    "estimatedtotaltransactionprice": 2500000,
    "deferredrevenuerevenuerecognized1": 2500000,
    "commonsharesregisteredandissued": 6960000,
    "descriptionofincometaxdescription": "The Company has Swiss tax loss carryforwards of $15.5 million as of December 31, 2020 (December 31, 2019: $11.5 million) of which $9.7 million will expire within the next five years, and $5.8 million will expire between 2025 - 2026.",
    "netcapitallosscarryforward": 15500000,
    "netoperatingloss": 9700000,
    "relatedpartytransactionsellinggeneralandadministrativeexpensesfromtransactionswithrelatedparty": 285859,
    "entityregistrantname": "NLS Pharmaceutics Ltd.\t",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 6960000,
    "amendmentflag": "false",
    "entitycentralindexkey": 1783036,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "entityincorporationstatecountrycode": "V8",
    "documentannualreport": "true",
    "documentshellcompanyreport": "false",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39957",
    "entityinteractivedatacurrent": "Yes"
  }
]